Job Description
Position: Digital Proxy Product Owner – Clinical Trials Risk Based Quality Management.
Location: Hyderabad
_This job offer is accessible to all, regardless of gender._
_About the job_
At Sanofi, we chase the miracles of science to improve people’s lives. Digital R&D’s mission is to bring the power of transformational technology to accelerate delivery of 1st in class, best in class medicines.
Sanofi’s R&D is leading significant increase in the number of Phase 3 studies, creating the greatest pipeline momentum in Sanofi’s history.
The Digital Clinical Trials Risk Based Quality Management Proxy Product Owner will directly contribute to this challenge : he/she will drive the product to accelerate clinical trials with data driven monitoring
**The Analytics Data Products Development Product Line is delivering 2 main products (** Proactive operations management with data driven decision making and Data Driven monitoring activities...
Location: Hyderabad
_This job offer is accessible to all, regardless of gender._
_About the job_
At Sanofi, we chase the miracles of science to improve people’s lives. Digital R&D’s mission is to bring the power of transformational technology to accelerate delivery of 1st in class, best in class medicines.
Sanofi’s R&D is leading significant increase in the number of Phase 3 studies, creating the greatest pipeline momentum in Sanofi’s history.
The Digital Clinical Trials Risk Based Quality Management Proxy Product Owner will directly contribute to this challenge : he/she will drive the product to accelerate clinical trials with data driven monitoring
**The Analytics Data Products Development Product Line is delivering 2 main products (** Proactive operations management with data driven decision making and Data Driven monitoring activities...
Ready to Apply?
Submit your application today and join our talented team at Sanofi Group.
Submit ApplicationJob Details
- Location Hyderabad, India
- Job Type Full-time
- Category other-general
- Posted Date June 29, 2026
- Application Deadline July 04, 2026